Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1465 of 5804
-
Heart failure drug may ease tissue congestion without harming blood flow
Disease control CompletedThe overall hypothesis is that treatment with the SGLT2 inhibitor Ertugliflozin induces a differential regulation in interstitial fluid vs plasma volume, with more reduction of the volume from the interstitial fluid than from the circulating plasma volume, which results in Ertugl…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug trial aims to ease skin hardening in rare autoimmune disease
Disease control Recruiting nowThe purpose of this study is to determine whether itacitinib is safe and effective in the treatment of systemic sclerosis in adults.
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Heartburn drug may shield cancer patients from nerve pain
Prevention CompletedOxaliplatin(OXA) chemotherapy protocols are used in treatment of cancers like colorectal (CRC) and pancreatic cancer. OXA causes peripheral neuropathy which is considered treatment limiting factor. In recent studies, it shows that omeprazole(OME) has antioxidant effect and can in…
Phase: PHASE3 • Sponsor: Aya Mohamed Sadek Elsaid • Aim: Prevention
Last updated Jun 26, 2026 15:11 UTC
-
Horse therapy shows promise for kids with ADHD
Symptom relief CompletedThe goal of this clinical trial is to develop and validate an Equine Assisted Occupational Therapy Intervention for children aged 6-12 with Attention Deficit Hyperactivity Disorder. The research aims to study the effect of an EAOT intervention on cognitive-emotional aspects, dai…
Phase: NA • Sponsor: Tel Aviv University • Aim: Symptom relief
Last updated Jun 26, 2026 14:38 UTC
-
Can virtual reality help kids with speech delays talk better?
Symptom relief ENROLLING_BY_INVITATIONThis study aims to test the effectiveness of virtual reality-supported speech therapy in improving basic language skills in children aged 3 to 6 years diagnosed with Developmental Language Disorder (DLD). Participants are randomly assigned to either traditional speech therapy or …
Phase: NA • Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New support program aims to ease burden for asian american dementia caregivers
Symptom relief OngoingThis study will conduct a two-arm randomized controlled trial to test the efficacy of a culturally tailored version of the NYU Caregiver Intervention (NYUCI) plus enhanced support (ES) through online chat groups (the NYUCI plus WeChat/Kakaotalk/other social media apps \[popular s…
Phase: NA • Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
10,000 healthy volunteers tracked for 20 years to unlock early cancer detection
Knowledge-focused Recruiting nowCancer produces a significant burden on society with a majority diagnosed at late stages when the chance of cure is low. Early diagnosis improves patient outcomes. Data consisting of lifestyle factors, medications, physical activity, years before conventional cancer diagnosis is …
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New study explores less invasive prostate cancer treatments
Disease control Recruiting nowThis study will be designed to define the efficacy and safety of ablative therapies in the management of localized prostate cancer and comprehensively evaluate quality of life outcomes and oncologic control following treatment.
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Texts and brain zaps: new combo for tough depression?
Symptom relief Recruiting nowThis study is a multicenter prospective, parallel design, two-arm, rater-blinded randomized controlled pilot trial. Participants will be randomly assigned to one of two treatment conditions. In the first condition, treatment consists of rTMS sessions combined with Text4Support. T…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Heart Scar-Guided ablation may cut AF recurrence
Disease control Recruiting nowThis is a multicenter, randomized controlled trial to compare the recurrence of 1-year atrial arrhythmia after catheter ablation of atrial fibrillation (AF) between pulmonary vein isolation (PVI) and PVI with additional left atrial (LA) substrate modification based on the left at…
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Brain scans may unlock better stroke rehab for veterans
Knowledge-focused Recruiting nowAfter a right brain stroke, \>50% of Veterans experience problems with dressing, eating, self-care or steering their wheelchairs because their ability to move, orient, and respond toward the left side is limited: spatial neglect. Spatial neglect prevents them from functioning ind…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New combo radiation approach aims to control advanced lung cancer
Disease control Recruiting nowThe aim of the study is to test the feasibility \& loco-regional control rate by combining high precision SBRT with chemotherapy in stage III NSCLC in tumor/lymph nodes if tumors/lymph node size with ≤ 6cms in size.
Phase: NA • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for PMR patients: drug may reduce need for steroids
Disease control CompletedPolymyalgia rheumatica (PMR) is prevalent among elderly. Untreated, it leads to major reduction in quality of life. Glucocorticoids are the cornerstone of treatment, but have drawbacks, warranting glucocorticoid sparing treatment. A proof of concept study on Rituximab (RTX) vs pl…
Phase: PHASE3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Breath sniffing device may spot head and neck cancer early
Diagnosis CompletedThis interventional diagnostic study evaluated a multi-channel artificial nose (UNos) medical device for analysis of exhaled breath in participants with head and neck squamous cell carcinoma and healthy volunteers. Participants underwent a standardized breath sampling procedure, …
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Tiny implant could spot hidden heart risk in millions
Knowledge-focused OngoingPatients with heart failure (HF) represent a large population of patients who are at high risk for complications related to undiagnosed atrial fibrillation (AF). However, currently there are limited modalities for early AF detection and subsequent stroke prevention in this high-r…
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New hope for bile duct cancer: immunotherapy plus chemo after surgery
Disease control Recruiting nowThis is an open-label,single center,non-randomized,single arm exploratory study. The objective of this study is to evaluate the efficacy and safety of PD-1 antibody plus GEMOX as postoperative adjuvant therapy in perihilar cholangiocarcinoma with positively metastatic lymph nodes…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Botswana study merges HIV and hypertension care to save lives
Disease control CompletedThe InterCARE research project proposes to leverage a successful national ART program to develop an effective package to improve the uptake of established effective hypertension and CVD risk factors management interventions among PLWHIV in Botswana and other low- and middle-incom…
Phase: NA • Sponsor: University of Botswana • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Personalized walking plan may boost fitness during breast cancer chemo
Symptom relief Recruiting nowIn this study, investigators will compare standard Aerobic Training/AT with adaptive Aerobic Training/AT. Standard AT will be a fixed (unchanging) amount of walking each week, while adaptive AT will adjust the level of exercise depending on participants' response to the exercise.…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Fat stem cells infused into kidney artery to fight transplant rejection
Disease control CompletedThis research study is being done to learn if an experimental treatment of infusing allogeneic adipose-derived mesenchymal stromal cells (allo-A-MSC ) directly into the renal artery is safe and can help reduce inflammation in the transplanted kidney and treat rejection.
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New balloon treatment for heart disease tested in first human study
Disease control OngoingThis prospective, single-arm, multi-center, safety and feasibility first-in-human study will evaluate the safety and feasibility of the SirPlux Duo™ Dual-API Coated PTCA Balloon Catheter to treat de-novo lesions between ≥2.0 and ≤4.0 mm in patients with symptomatic stable angina,…
Phase: NA • Sponsor: Advanced NanoTherapies • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC